DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. ARP Research Highlights/News
  3. FY14 Autism Research Program

NEWS RELEASE

Released: March 19, 2014

Defense Health Program
Department of Defense Autism Research Program
Funding Opportunities for Fiscal Year 2014

The FY14 Defense Appropriations Act provides $6 million (M) to the Department of Defense Autism Research Program (ARP) ) to support innovative, high-impact autism spectrum disorder research. This program is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

The ARP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY14 ARP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website in April 2014. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government. Funding is contingent upon receipt of appropriations.

Award Mechanism Principal Investigator (PI) Eligibility Key Mechanism Elements FY14 Areas of Interest
(Encouraged)		 Funding
Clinical Trial Award Investigators at or above the level of Associate Professor (or equivalent)
  • Supports research with the potential to have a major impact on the treatment and/or management of ASD.
  • Preliminary data relevant to the proposed project are required.
  • Pre-application is required; application submission is by invitation only.
  • Behavioral and other non-pharmacological therapies
  • Pharmacological treatments in autism or well-defined subgroups of autism (e.g., genetic, phenotypic, co-occurring conditions)
  • Dissemination/Implementation of established, efficacious behavioral interventions
  • Therapies to alleviate conditions co-occurring with ASD (e.g., sleep disturbances, gastro-intestinal issues, aggression, depression, anxiety)
  • Maximum funding for the entire period of performance is $1,000,000 in direct costs (plus indirect costs)
  • Maximum period of performance is 5 years
Idea Development Award Investigators at all academic levels (or equivalent)
  • Supports the development of innovative, high-impact ideas that advance the understanding of ASD and ultimately lead to improved outcomes.
  • Preliminary data are required.
  • Multiple Principal Investigator (PI) Option: Up to three investigators may collaborate on a single application, each of whom will be recognized as a PI and receive a separate award.
  • Pre-application is required; application submission is by invitation only.
  • Environmental risk factors
  • Mechanisms of heterogeneous clinical expression or response to treatment of ASD, excluding new gene discovery
  • Mechanisms underlying conditions co-occurring with ASD (e.g., sleep disturbances, gastro-intestinal issues, aggression, depression, anxiety)
  • Novel therapeutics using valid preclinical models
  • Psychosocial factors promoting success in key transitions to independence for individuals living with ASD
  • Maximum funding for the entire period of performance is $335,000 in direct costs (plus indirect costs)
  • For multiple PIs, the combined funding for all PIs for the entire period of performance may not exceed $335,000 in direct costs (plus indirect costs)
  • Maximum period of performance is 3 years

All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Pre-applications are required and must be submitted through the CDMRP electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org). Applications must be submitted through the federal government’s single-entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released. Requests for email notification of the Program Announcements release may be sent to help@eBRAP.org. Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.

For more information about the BCRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.health.mil).

Point of Contact:

CDMRP Public Affairs
301-619-9783
usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil